B01D15/424

CONVERSION OF AROMATIC COMPLEX BOTTOMS TO USEFUL PRODUCTS IN AN INTEGRATED REFINERY PROCESS

Systems and integrated methods are disclosed for processing aromatic complex bottoms into high value products. The system includes an adsorption column, the adsorption column in fluid communication with an aromatics complex and operable to receive and remove polyaromatics from an aromatic bottoms stream. The adsorption column producing a cleaned aromatic bottoms stream with reduced polyaromatic content and a reject stream including the removed polyaromatics. In some embodiments, the reject stream is recycled for further processing, passed to a coke production unit to produce high quality coke, or both.

BIOREACTOR ARRANGEMENT AND CONTINUOUS PROCESS FOR PRODUCING AND CAPTURING A BIOPOL YMER
20220185868 · 2022-06-16 · ·

Provided is a bioreactor arrangement for producing a biopolymer expressed by a cell and a continuous process for a capturing the biopolymer employing two chromatography units operated in series or independently.

Ultra-pure agonists of guanylate cyclase C, method of making and using same

The invention provides processes of purifying a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-251 described herein. The processes include a solvent exchange step before a freeze-drying (lyophilization) step.

Bioreactor arrangement and continuous process for producing and capturing a biopolymer
11286292 · 2022-03-29 · ·

The present invention relates to a bioreactor arrangement for producing a biopolymer expressed by a cell and a continuous process for a capturing the biopolymer employing two chromatography units operated in series or independently.

Devices and methods for plasmid purification

The invention provides columns (including pipette tip columns) and automated methods for the purification of nucleic acids including plasmids. Nucleic acids can be purified from unclarified, clarified or partially-clarified cell lysates that contain cell debris. The columns typically include a bed of medium positioned above a bottom frit and with an optional top frit. Plasmid preparation scales include miniprep, midiprep, maxiprep, megaprep and gigaprep.

Ultra-pure agonists of guanylate cyclase C, method of making and using same

The invention provides processes of purifying a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-251 described herein. The processes include a solvent exchange step before a freeze-drying (lyophilization) step.

Chromatography system and method for capturing a biopolymer
11267869 · 2022-03-08 · ·

The present invention relates to a chromatography system (20) wherein the chromatography system comprises an eluting system (10) and a capturing system (11) consisting of at least two chromatography units (2,3) operated alone or in series and a capturing process employing in-line buffer dilution in, which concentrated buffers are blended with water and provided to the chromatography units.

Use of compressed gas for moving eluent applied to chromatography
11154795 · 2021-10-26 · ·

The invention relates to a method for chromatographic separation, comprising at least one step of elution of species held on a stationary phase by means of an eluent, followed by a step of moving the eluent in contact with the stationary phase by means of a compressed gas. Preferably, the movement step takes place after a step of elution of the product(s) of interest and/or after a step of regeneration of the stationary phase.

Extracellular vesicle isolation method using metal

An extracellular vesicle isolation method using a metal, and a method for isolating extracellular vesicles from various samples using metal affinity are disclosed. An extracellular vesicle isolation method has the advantages of not requiring costly equipment, of being able to be applied without limits on sample quantity, and of being capable of efficiently isolating extracellular vesicles while preserving the shape or properties thereof. Moreover, the method can be combined with existing isolation methods to maximize the efficiency of extracellular vesicle isolation, and can be utilized in disease diagnosis, disease treatment, multi-omics research, and extracellular vesicle property research and the like using the isolated extracellular vesicles.

COMPOSITIONS AND METHODS FOR MANUFACTURING GENE THERAPY VECTORS
20210355503 · 2021-11-18 ·

Disclosed are methods for the production and/or purification of a recombinant AAV (rAAV) particle from a mammalian host cell culture.